CREP2, Quantitative determination of the concentration of creatine in human serum, plasma and urine developed for purpose is an enzymatic in vitro diagnostic test. This test, Roche/Hitachi cobas c systems works fully compatible with the laboratories. High accuracy, repeatability and quick result It offers. It is an ideal solution for precise measurement of the levels of the creatinine, which plays a critical role in evaluation of kidney functions.
Compatible Systems
- cobas c 703
- cobas c 303
- cobas c 503
- cobas c 111
- cobas c 311
- cobas c 502
Clinical Importance of Test
Creatine levels, mainly kidney diseases It is used in diagnosis and tracking of various metabolic disorders. CREP2 test, enzymatic method thanks to less sensitive to interferans, and especially ikteric, hemolytic or lipemic examples Provides more accurate results.
Enzymatic tests compared to traditional Jaffe method:
- Higher selfishness
- Clinically meaningful minor changes can be detected.
- It can be safely used in areas requiring sensitive monitoring such as intensive care, cardiology and nephrology.
Technical Advantages
- Sensitive enzymatic methodology
- Wide application area in serum, plasma and urine
- With full automatic analysis process improves laboratory efficiency
- cobas optimized performance on c platforms
- With advanced calibration technology consistent results
Tilia Medical About Us CREP2 Easy Access to Test
Tilia Medical As, Roche Diagnostics authorized supplier of products We are proud to provide high-quality healthcare solutions. CREP2 Advantages of working with us on sensitive diagnostic tools such as test:
- Original and certified product warranty
- All cobas suitable systems fast product supply
- Expert technical support and installation advice
- Competitive prices and flexible supply solutions
- Goods suitable for the regulations of health authorities
